- Report
- April 2025
- 50 Pages
Global
From €2425EUR$2,650USD£2,107GBP
- Report
- August 2022
- 120 Pages
Global
From €4118EUR$4,500USD£3,578GBP
- Report
- April 2025
- 50 Pages
Global
From €2425EUR$2,650USD£2,107GBP
Dicycloverine is a drug used to treat gastrointestinal disorders, such as irritable bowel syndrome, peptic ulcers, and diverticulitis. It is an antispasmodic, meaning it helps to relax the muscles of the digestive tract, reducing pain and discomfort. It is also used to treat other conditions, such as bladder spasms and menstrual cramps. Dicycloverine is available in both oral and injectable forms.
The dicycloverine market is a niche market, with a limited number of manufacturers. It is mainly used in the treatment of gastrointestinal disorders, and is not widely used for other conditions. The market is highly competitive, with a number of generic and branded products available.
Some companies in the dicycloverine market include Pfizer, Merck, Novartis, and Sanofi. Show Less Read more